Microsatellite analysis in multistage carcinogenesis of esophageal squamous cell carcinoma from Chongqing in Southern China

International Journal of Molecular Sciences

Volumn 12, Issue 11, 2011, Pages 7401-7409

  Liu, Ming ^a   Zhang, Feng ^b   Liu, Shen ^a   Zhao, Wen ^a   Zhu, Jing ^a   Zhang, Xiaoli ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Chinese Academy of Sciences and China National Center for Bioinformation   (China)

Author keywords

Esophageal squamous cell carcinoma; Loss of heterozygosity; Microsatellite

Indexed keywords

BIOLOGICAL MARKER; GENETIC MARKER; MICROSATELLITE DNA;

ADULT; AGED; ALLELE; ARTICLE; CANCER STAGING; CARCINOGENESIS; CHINA; CHROMOSOME 11P; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 3P; CHROMOSOME 4P; CHROMOSOME 5Q; CHROMOSOME 8P; CHROMOSOME 9P; CHROMOSOME 9Q; CONTROLLED STUDY; DYSPLASIA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MICROSATELLITE MARKER; MOLECULAR PATHOLOGY; POLYMERASE CHAIN REACTION; TISSUE SECTION; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION; ESOPHAGEAL NEOPLASMS; GENETIC MARKER; GENETICS; MIDDLE AGED;

ADULT; AGED; ALLELES; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC LOCI; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED;

EID: 82255181788     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12117401     Document Type: Article

References (20)

1. Maley, C.C.; Galipeau, P.C.; Li, X.; Sanchez, C.A.; Paulson, T.G.; Blount, P.L.; Reid, B.J. The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res. 2004, 64, 7629-7633.
2. Maitra, A.; Wistuba, I.I.; Washington, C.; Virmani, A.K.; Ashfaq, R.; Milchgrub, S.; Gazdar, A.F.; Minna, J.D. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am. J. Pathol. 2001, 159, 119-130.
3. Wang, Z.; Lai, F.M. Analysis of loss of heterozygosity on chromosome 8 in human prostate carcinoma and high grade prostatic intraepithelial neoplasia. Zhonghua Nan Ke Xue 2004, 10, 26-31.
4. Karakosta, A.; Golias, C.; Charalabopoulos, A.; Peschos, D.; Batistatou, A.; Charalabopoulos, K. Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia. J. Exp. Clin. Cancer Res. 2005, 24, 505-514.
5. Ha, P.K.; Pilkington, T.A.; Westra, W.H.; Sciubba, J.; Sidransky, D.; Califano, J.A. Progression of microsatellite instability from premalignant lesions to tumors of the head and neck. Int. J. Cancer 2002, 102, 615-617.
6. Dawsey, S.M.; Lewin, K.J.; Wang, G.Q.; Liu, F.S.; Nieberg, R.K.; Yu, Y.; Li, J.Y.; Blot, W.J.; Li, B.; Taylor, P.R. Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China. Cancer 1994, 74, 1686-1692.
7. Shen, D.; Nooraie, F.; Elshimali, Y.; Lonsberry, V.; He, J.; Bose, S.; Chia, D.; Seligson, D.; Chang, H.R.; Goodglick, L. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum. Pathol. 2006, 37, 1583-1591.
8. Zhou, G.; Li, H.; DeCamp, D.; Chen, S.; Shu, H.; Gong, Y.; Flaig, M.; Gillespie, J.W.; Hu, N.; Taylor, P.R. et al. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell Proteomics 2002, 1, 117-124.
9. Yang, L.; Leung, A.C.; Ko, J.M.; Lo, P.; Tang, J.; Srivastava, G.; Oshimura, M.; Stanbridge, E.; Daigo, Y.; Nakamura, Y. et al. Tumor suppressive role of a 2.4 Mb 9q33-q34 critical region and DEC1 in esophageal squamous cell carcinoma. Oncogene 2005, 24, 697-705.
10. Huang, X.P.; Wei, F.; Liu, X.Y.; Xu, X.; Hu, H.; Chen, B.; Xia, S.; Han, Y.; Han, Y.; Cai, Y. et al. Allelic loss on 13q in esophageal squamous cell carcinomas from northern China. Cancer Lett. 2002, 185, 87-94.
11. Hu, N.; Huang, J.; Emmert-Buck, M.R.; Tang, Z.Z.; Roth, M.J.; Wang, C.; Dawsey, S.M.; Li, G.; Li, W.J.; Wang, Q.H. et al. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Clin. Cancer Res. 2001, 7, 883-891.
12. Koppert, L.B.; Wijnhoven, B.P.; van Dekken, H.; Tilanus, H.W.; Dinjens, W.N. The molecular biology of esophageal adenocarcinoma. J. Surg. Oncol. 2005, 92, 169-190.
13. Partridge, M.; Pateromichelakis, S.; Phillips, E.; Emilion, G.; Langdon, J. Profiling clonality and progression in multiple premalignant and malignant oral lesions identifies a subgroup of cases with a distinct presentation of squamous cell carcinoma. Clin. Cancer Res. 2001, 7, 1860-1866.
14. Cheng, L.; Bostwick, D.G.; Li, G.; Wang, Q.; Hu, N.; Vortmeyer, A.O.; Zhuang, Z. Allelic imbalance in the clonal evolution of prostate carcinoma. Cancer 1999, 85, 2017-2022.
15. Heim, S.; Teixeira, M.R.; Dietrich, C.U.; Pandis, N. Cytogenetic polyclonality in tumors of the breast. Cancer Genet. Cytogenet. 1997, 95, 16-19.
16. He, S.; Guo, G.M.; Liu, F.X.; Huang, X.P.; Xu, X.; Cai, Y.; Han, Y.L.; Zhan, Q.M.; Wu, M.; Dong, J.T. et al. Molecular analysis in combination with iodine staining may contribute to the risk prediction of esophageal squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 2008, 134, 307-315.
17. Dawsey, S.M.; Lewin, K.J.; Liu, F.S.; Wang, G.Q.; Shen, Q. Esophageal morphology from Linxian, China. Squamous histologic findings in 754 patients. Cancer 1994, 73, 2027-2037.
18. The Genome Database. Available online: http://www.gdb.org/ (accessed on 15 October 2009).
19. The NCBI genome database. Available online: http://www.ncbi.nlm.nih.gov/ (accessed on 7 November 2009).
20. Zhang, X.L.; Fu, W.L.; Zhao, H.X.; Zhou, L.X.; Huang, J.F.; Wang, J.H. Molecular studies of loss of heterozygosity in Chinese sporadic retinoblastoma patients. Clin. Chim. Acta 2005, 358, 75-80.